1. Home
  2. CMPX vs LFMD Comparison

CMPX vs LFMD Comparison

Compare CMPX & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$0.98

Market Cap

203.5M

Sector

Health Care

ML Signal

HOLD

Logo LifeMD Inc.

LFMD

LifeMD Inc.

SELL

Current Price

$2.66

Market Cap

218.1M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CMPX
LFMD
Founded
2014
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
203.5M
218.1M
IPO Year
2020
2012

Fundamental Metrics

Financial Performance
Metric
CMPX
LFMD
Price
$0.98
$2.66
Analyst Decision
Buy
Strong Buy
Analyst Count
15
8
Target Price
$5.45
★ $8.13
AVG Volume (30 Days)
★ 5.3M
775.3K
Earning Date
11-04-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 141.67
EPS
★ N/A
N/A
Revenue
N/A
★ $12,468,578.00
Revenue This Year
N/A
$7.00
Revenue Next Year
N/A
$18.09
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 49.79
52 Week Low
$0.89
$2.60
52 Week High
$6.88
$6.68

Technical Indicators

Market Signals
Indicator
CMPX
LFMD
Relative Strength Index (RSI) 22.99 31.73
Support Level N/A N/A
Resistance Level $2.08 $3.46
Average True Range (ATR) 0.10 0.14
MACD -0.02 -0.02
Stochastic Oscillator 10.29 2.72

Price Performance

Historical Comparison
CMPX
LFMD

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

About LFMD LifeMD Inc.

LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.

Share on Social Networks: